US FDA Approves Boostrix for Immunization During Pregnancy for the Prevention of Whooping Cough in Newborn Infants

Boostrix is the first vaccine in the US indicated to help protect infants younger than two months from pertussis (whooping cough) 10 October 2022 -- GSK plc (LSE/NYSE: GSK) today announced that the US Food and Drug Administration (FDA) has...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news